Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115340) titled 'Diagnostic Value of [18F]-fluorodopa(dopa) in Parkinsonian Syndromes' on Dec. 24, 2025.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Huashan Hospital, Fudan University
Condition:
Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy
Intervention:
Patients with Parkinson's Disease:None
Patients with Multiple System Atrophy:None
Patients with Progressive Supranuclear Palsy:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-31
Target Sample Size: Patients with Parkinson's Disease:20;Patients with Multiple Sy...